Better by design: What to expect from novel CAR-engineered cell therapies?
Sign Up to like & getrecommendations! Published in 2022 at "Biotechnology advances"
DOI: 10.1016/j.biotechadv.2022.107917
Abstract: Chimeric antigen receptor (CAR) technology, and CAR-T cells in particular, have emerged as a new and powerful tool in cancer immunotherapy since demonstrating efficacy against several hematological malignancies. However, despite encouraging clinical results of CAR-T… read more here.
Keywords: cell therapies; car engineered; novel car; engineered cell ... See more keywords